AVANOS MEDICAL, INC. Quarterly Interest Expense in USD from Q3 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Avanos Medical, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2013 to Q1 2024.
  • Avanos Medical, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.1M, a 11.4% decline year-over-year.
  • Avanos Medical, Inc. Interest Expense for the twelve months ending March 31, 2024 was $14.6M, a 19.7% increase year-over-year.
  • Avanos Medical, Inc. annual Interest Expense for 2023 was $15M, a 50% increase from 2022.
  • Avanos Medical, Inc. annual Interest Expense for 2022 was $10M, a 203% increase from 2021.
  • Avanos Medical, Inc. annual Interest Expense for 2021 was $3.3M, a 78.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $14.6M $3.1M -$400K -11.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $15M $3.3M +$300K +10% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $14.7M $4.7M +$1.7M +56.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $13M $3.5M +$800K +29.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $12.2M $3.5M +$2.2M +169% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $10M $3M +$2.3M +329% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $7.7M $3M +$2.1M +233% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $5.6M $2.7M +$1.8M +200% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $3.8M $1.3M +$500K +62.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $3.3M $700K -$2M -74.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $5.3M $900K -$3.4M -79.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $8.7M $900K -$3.4M -79.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $12.1M $800K -$3.5M -81.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $15.6M $2.7M -$1.6M -37.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $17.2M $4.3M +$800K +22.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $16.4M $4.3M +$800K +22.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $15.6M $4.3M +$600K +16.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $15M $4.3M +$800K +22.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $14.2M $3.5M -$700K -16.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $14.9M $3.5M -$6.4M -64.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $21.3M $3.7M -$5.1M -58% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $26.4M $3.5M -$4.6M -56.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $31M $4.2M -$3.9M -48.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $34.9M $9.9M +$2.1M +26.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $32.8M $8.8M +$1.2M +15.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $31.6M $8.1M +$100K +1.25% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $31.5M $8.1M -$300K -3.57% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-12-17
Q2 2017 $31.8M $7.8M -$500K -6.02% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $32.3M $7.6M -$400K -5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $32.7M $8M -$100K -1.24% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $32.8M $8.4M +$600K +7.69% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $32.2M $8.3M -$600K -6.74% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $32.8M $8M -$300K -3.61% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $33.1M $8.1M +$2.2M +37.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $30.9M $7.8M +$7.7M +7700% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $23.2M $8.9M +$8.9M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $14.3M $8.3M +$8.3M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $6M $5.9M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $100K +$100K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.